What is Luci?

Luci is an app created with the objective to help reduce risks of cognitive decline and Alzheimer’s disease by adopting healthy lifestyle habits.

Luci will be right there with you as you work to adopt and maintain habits that promote brain health: healthy eating, physical activity and intellectual stimulation.

The world will have to wait…

Luci’s not available in English yet, but you can access the French version today.

Bring me to the app

Let's get to know you

Answer a few questions and get an overview of your current lifestyle habits.

Meet your advisor

Discuss with your advisor by video or chat. Their role is to support you in your journey.

Start improving

Follow your personalized action plan and gradually adopt lifestyle habits that support brain health.

Our mission

Help reduce risks of Alzheimer’s disease

Our goal is to promote healthy lifestyle habits known for their protective effect on the brain. Our program is based on proven behavioral change theories.

Learn more

Maladie

Today, nearly half a million Canadians are living with some form of dementia.

Sadly, that number grows every year and with it, grows the financial cost of providing adequate healthcare to the people afflicted.

Exercise

By simply taking part in some form of physical activity every day,

you can help increase your ability to concentrate, improve your reflexes and brighten your mood. Imagine the long-term benefits!

Nutrition

Mediterranean diet: the brain's favorite

According to several studies, it can reduce by up to 40% the risk of developing Alzheimer’s disease as people age.

Santé cognitive

If there’s one thing your brain really loves, it’s a change in routine.

By adding the element of surprise and novelty to your daily life, you can help keep your brain active and reduce the risk of developing Alzheimer's disease!

An application rooted in science

Our researchers and scientific committee work hand in hand to further advancements in the understanding and improvement of cognitive health. The Luci app will undergo a series of clinical validations starting in September 2020. The results will be made accessible to the entire scientific community.